NCT04267575 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- Data has been collected for 16 months as of 5/21/21
- Other-event reporting threshold
- 0%
There have been 0 adverse events.
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Primary Arm | 0 / 20 | 0 / 20 | 2 / 20 |
Serious adverse events
Other reported adverse events
Complete source fields
- description
- There have been 0 adverse events.
- event Groups
- deaths Num Affected
- 2
- deaths Num At Risk
- 20
- description
- Patients received previous chemotherapy, radiation, immuno-therapy and/or surgery prior to metastatic recurrent disease. In this study, the patients gross solid tumor was removed, and cold plasma was sprayed in the area of the resected tumor margins. Canady Helios Cold Plasma Scalpel: Device used to distribute cold plasma energy at the resected tumor margins. Post-operatively, patients will be started back on Adjuvant chemotherapy, radiation, or immuno-therapy as per medical oncology and multi-disciplinary team.
- id
- EG000
- other Num Affected
- 0
- other Num At Risk
- 20
- serious Num Affected
- 0
- serious Num At Risk
- 20
- title
- Primary Arm
- frequency Threshold
- 0
- time Frame
- Data has been collected for 16 months as of 5/21/21
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle